Meldonium, the anti-ischemic drug that led to Maria Sharapova’s suspension, is witnessing a surge in popularity in the nootropics (“smart drugs”) community.
“I have noticed a huge increase in meldonium sales over the last days; all people [are] coming in to buy meldonium,” Ricardas Tarvydas, who runs the website nootropic.eu, told me in a phone call from Lithuania, where he buys most of his products.
Tarvydas explained that he usually sells just a couple of boxes of meldonium (also known as mildronate) every month; over the last 24 hours, though, he said he had received orders for 870 boxes. Some of Tarvydas’s customers explicitly mentioned Sharapova when placing their orders.
The Russian tennis player revealed on Monday that she had tested positive for meldonium, also known as mildronate, which the World Anti-Doping Agency (WADA) banned last January. Sharapova claimed she hadn’t noticed the ban on the medicine, which she had been lawfully taking for a decade.
The case has triggered a sudden spike in interest in meldonium online and rekindled the curiosity of the relatively niche “noonauts” community—folks looking to enhance their cognitive performance using nootropics.
Read More…
Source Article from http://feedproxy.google.com/~r/blacklistednews/hKxa/~3/rtYZqhY-Jfw/M.html
Related posts:
Views: 0